Literature DB >> 7201097

Kinetics of carnitine-dependent fatty acid oxidation: implications for human carnitine deficiency.

C S Long, R G Haller, D W Foster, J D McGarry.   

Abstract

The relationship between the concentration of carnitine and the oxidation of oleate was examined in homogenates prepared from skeletal muscle, liver, kidney, and heart of the rat, and from canine and human skeletal muscle. the carnitine content of these tissues in situ spanned a wide range, from about 0.1 mumol per gram in rat liver to about 3.0 mumol per gram in human muscle. The concentration of carnitine required for half-maximal rates of fatty acid oxidation in vitro also varied greatly (10 to 15 microM for rat liver to 200 to 400 microM for human muscle), and in rough proportion to the normal carnitine content of the tissues. For any given tissue, the carnitine content seems to be set at a level necessary for optimal rates of fatty acid oxidation. The data provide a plausible explanation for the fact that muscle fatty acid metabolism is severely impaired in the syndrome of human carnitine deficiency, since measured carnitine levels are in the range expected to limit substantially the capacity for fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201097     DOI: 10.1212/wnl.32.6.663

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Ontogeny and kinetics of carnitine palmitoyltransferase I in hepatopancreas and skeletal muscle of grass carp (Ctenopharyngodon idella).

Authors:  Wei Hu; Zhi Luo; Kang-Sen Mai; Cai-Xia Liu; Jia-Lang Zheng
Journal:  Fish Physiol Biochem       Date:  2015-07-15       Impact factor: 2.794

2.  Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner.

Authors:  Victor Pashkov; Jie Huang; Vinay K Parameswara; Wojciech Kedzierski; Deborah M Kurrasch; Gregory G Tall; Victoria Esser; Robert D Gerard; Kosaku Uyeda; Howard C Towle; Thomas M Wilkie
Journal:  J Biol Chem       Date:  2011-02-27       Impact factor: 5.157

3.  A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome.

Authors:  Jon D Kaiser
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Palmitate oxidation by the mitochondria from volume-overloaded rat hearts.

Authors:  B Christian; Z El Alaoui-Talibi; M Moravec; J Moravec
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 5.  Carnitine deficiency-induced cardiomyopathy.

Authors:  D J Paulson
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

6.  Interacting effects of L-carnitine and malonyl-CoA on rat liver carnitine palmitoyltransferase.

Authors:  M I Bird; E D Saggerson
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

7.  Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat.

Authors:  J D McGarry; S E Mills; C S Long; D W Foster
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

8.  Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I.

Authors:  S E Mills; D W Foster; J D McGarry
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

9.  Carnitine and physical exercise.

Authors:  O J Heinonen
Journal:  Sports Med       Date:  1996-08       Impact factor: 11.136

10.  Kinetics of carnitine palmitoyltransferase I (CPT I) in Chinese sucker (Myxocyprinus asiaticus) change with its development.

Authors:  Cai-Xia Liu; Zhi Luo; Wei Hu; Xiao-Ying Tan; Jia-Lang Zheng; Qi-Liang Chen; Qing-Ling Zhu
Journal:  Lipids       Date:  2013-11-22       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.